Page 11 - 202002
P. 11

内分泌代谢杂志, 2008, 24(6): 616-619.                       review  and  meta-analysis  of  randomized

                                                              controlled  trials  [J].  Endocrine,  2016,
              [9]  Yang  W,  Gao  Y,  Liu  G,  et  al.
         Biphasic  insulin  aspart  30  as  insulin           51(3):417-28.
         initiation  or  replacement  therapy:  the                [16] Yavuz DG, Ozcan S, Deyneli O.

         China  cohort  of  the  IMPROVE  study[J].           Adherence to insulin treatment in insulin-
         Curr  Med  Res  Opin,  2010,  26(1):  101-           naïve type 2 diabetic patients initiated on
         107.                                                 different  insulin  regimens  [J].  Patient

              [10] 纪立农,冯波,苏青,等.使用口服降                          Prefer Adherence, 2015,25(9):1225-31.

         糖药血糖控制欠佳的中国2型糖尿病患者起                                       [17] Vora J, Cohen N, Evans M, et al.
         始胰岛素治疗现状[J].中国糖尿病杂志,                                 Intensifying  insulin  regimen  after  basal

         2011, 19 (10): 746-751.                              insulin  optimization  in  adults  with  type  2

              [11]杨文英,李玉秀,陈莉明,等.双时相                           diabetes:  a  24-week,  randomized,  open-
         门冬胰岛素30在中国人群中的临床应用                                   label trial comparing insulin glargine plus
         ——A1chieve观察性研究结果[J].中华糖尿                            insulin  glulisine  with  biphasic  insulin

         病杂志, 2012, 4(10):607-612.                            aspart  (LanScape)  [J].  Diabetes  Obes
                                                              Metab, 2015, 17(12):1133-41.
              [12] Garber AJ, Wahlen J, Wahl T, et
         al. Attainment of glycaemic goals in type

         2  diabetes  with  once-,  twice-,  or  thrice-
         daily  dosing  with  biphasic  insulin  aspart

         70/30(The 1-2-3 study)[J]. Diabetes Obes
         Metab, 2006,8(1): 58-66.

              [13] Yang W, Ersoy C, Wang G, et al.

         Efficacy  and  safety  of  three-times-daily
         versus twice daily biphasic insulin aspart
         30  in  patients  with  type  2  diabetes

         mellitus  inadequately  controlled  with
         basal     insulin    combined        with    oral
         antidiabetic  drugs  [J].  Diabetes  Res  Clin                      图 4200研究英文原文截图

         Pract,2019, 150:158-166.

              [14] 《2型糖尿病起始胰岛素后方案转                              作者简介
         换的临床指导建议》编写委员会.中华糖尿                                       杨文英 主任医师、博士生及博士后导

         病杂志,2018,10(2)97-102.                                师。 曾任中日友好医院内分泌代谢病中心
                                                              主任,大内科教研室主任,大内科主任,
              [15] Giugliano D, Chiodini P, Maiorino          医院学术委员会主任。 曾任中华医学会糖
         MI,et  al.  Intensification  of  insulin  therapy    尿病分会主任委员;亚洲糖尿病学会副主

         with  basal-bolus  or  premixed  insulin             席;曾任《中华糖尿病杂志》主编,现任
         regimens in type 2 diabetes: a systematic
                                                              荣誉主编;2012获得北京市科技进步一等



                                                          c̈́ḤḤc
   6   7   8   9   10   11   12   13   14   15   16